Detalhe da pesquisa
1.
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.
Mol Cell Proteomics
; 22(10): 100629, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37557955
2.
A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration.
Int J Mol Sci
; 23(13)2022 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806226
3.
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.
Alzheimers Res Ther
; 16(1): 34, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355535
4.
Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia.
Alzheimers Res Ther
; 15(1): 62, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964594
5.
Multi-Omics Interdisciplinary Research Integration to Accelerate Dementia Biomarker Development (MIRIADE).
Front Neurol
; 13: 890638, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903119